HL7 Europe Foundation, 38-40 Square de Meeus, Brussels, 1000, Belgium; Healthropy Srl, Corso Vittorio Veneto 14B, Savona, 17100, Italy.
HL7 Europe Foundation, 38-40 Square de Meeus, Brussels, 1000, Belgium; MEDCIDS - Faculty of Medicine of University of Porto, Porto, Portugal; PDH - Pharma Data Hub, Porto, Portugal.
Int J Med Inform. 2024 Sep;189:105507. doi: 10.1016/j.ijmedinf.2024.105507. Epub 2024 Jun 4.
The prevalence of chronic diseases has shifted the burden of disease from incidental acute inpatient admissions to long-term coordinated care across healthcare institutions and the patient's home. Digital healthcare ecosystems emerge to target increasing healthcare costs and invest in standard Application Programming Interfaces (API), such as HL7 Fast Healthcare Interoperability Resources (HL7 FHIR) for trusted data flows.
This scoping review assessed the role and impact of HL7 FHIR and associated Implementation Guides (IGs) in digital healthcare ecosystems focusing on chronic disease management.
To study trends and developments relevant to HL7 FHIR, a scoping review of the scientific and gray English literature from 2017 to 2023 was used.
The selection of 93 of 524 scientific papers reviewed in English indicates that the popularity of HL7 FHIR as a robust technical interface standard for the health sector has been steadily rising since its inception in 2010, reaching a peak in 2021. Digital Health applications use HL7 FHIR in cancer (45 %), cardiovascular disease (CVD) (more than 15 %), and diabetes (almost 15 %). The scoping review revealed that references to HL7 FHIR IGs are limited to ∼ 20 % of articles reviewed. HL7 FHIR R4 was most frequently referenced when the HL7 FHIR version was mentioned. In HL7 FHIR IGs registries and the internet, we found 35 HL7 FHIR IGs addressing chronic disease management, i.e., cancer (40 %), chronic disease management (25 %), and diabetes (20 %). HL7 FHIR IGs frequently complement the information in the article.
HL7 FHIR matures with each revision of the standard as HL7 FHIR IGs are developed with validated data sets, common shared HL7 FHIR resources, and supporting tools. Referencing HL7 FHIR IGs cataloged in official registries and in scientific publications is recommended to advance data quality and facilitate mutual learning in growing digital healthcare ecosystems that nurture interoperability in digital health innovation.
慢性病的流行使得疾病负担从偶然的急性住院患者转变为医疗机构和患者家庭之间的长期协调护理。数字医疗生态系统应运而生，以应对不断增长的医疗成本，并投资于标准应用程序编程接口 (API)，例如 HL7 Fast Healthcare Interoperability Resources (HL7 FHIR)，以实现可信的数据流动。
本范围综述评估了 HL7 FHIR 及其相关实施指南 (IG) 在专注于慢性病管理的数字医疗生态系统中的作用和影响。
为了研究与 HL7 FHIR 相关的趋势和发展，对 2017 年至 2023 年期间的科学和灰色英语文献进行了范围综述。
从 524 篇英文科学论文中选择了 93 篇，表明自 2010 年成立以来，HL7 FHIR 作为卫生部门强大技术接口标准的受欢迎程度稳步上升，在 2021 年达到顶峰。数字健康应用程序在癌症 (45%)、心血管疾病 (CVD)(超过 15%)和糖尿病 (近 15%)中使用 HL7 FHIR。范围综述显示，参考 HL7 FHIR IG 的文章限制在审查文章的约 20%。在提到 HL7 FHIR 版本时，最常提到 HL7 FHIR R4。在 HL7 FHIR IG 注册表和互联网中，我们发现了 35 个针对慢性病管理的 HL7 FHIR IG，即癌症 (40%)、慢性病管理 (25%)和糖尿病 (20%)。HL7 FHIR IG 经常补充文章中的信息。
随着 HL7 FHIR IG 的开发，随着标准的每次修订，HL7 FHIR 都会不断成熟，这些 IG 具有经过验证的数据集、共同的共享 HL7 FHIR 资源和支持工具。建议参考官方注册表和科学出版物中编目的 HL7 FHIR IG，以提高数据质量，并促进不断发展的数字医疗生态系统中的相互学习，这些生态系统促进了数字健康创新中的互操作性。
Zotero 插件